AAAAAA
Results:
1-7
|
Results: 7
Authors:
LUKKARI E
TAAVITSAINEN P
JUHAKOSKI A
PELKONEN O
Citation: E. Lukkari et al., CYTOCHROME-P450 SPECIFICITY OF METABOLISM AND INTERACTIONS OF OXYBUTYNIN IN HUMAN LIVER-MICROSOMES, Pharmacology & toxicology, 82(4), 1998, pp. 161-166
Authors:
LUKKARI E
HAKONEN T
NEUVONEN PJ
Citation: E. Lukkari et al., THE PHARMACOKINETICS OF OXYBUTYNIN IS UNAFFECTED BY GENDER AND CONTRACEPTIVE STEROIDS, European Journal of Clinical Pharmacology, 53(5), 1998, pp. 351-354
Authors:
LUKKARI E
ARANKO K
JUHAKOSKI A
HAKONEN T
NEUVONEN PJ
Citation: E. Lukkari et al., EFFECT OF TIME-INTERVAL BETWEEN FOOD AND DRUG INGESTION ON THE ABSORPTION OF OXYBUTYNIN FROM A CONTROLLED-RELEASE TABLET, Pharmacology & toxicology, 81(1), 1997, pp. 31-34
Authors:
NILSSON CG
LUKKARI E
HAARALA M
KIVELA A
HAKONEN T
KIILHOLMA P
Citation: Cg. Nilsson et al., COMPARISON OF A 10-MG CONTROLLED-RELEASE OXYBUTYNIN TABLET WITH A 5-MG OXYBUTYNIN TABLET IN URGE INCONTINENT PATIENTS, Neurourol. urodyn., 16(6), 1997, pp. 533-542
Authors:
LUKKARI E
JUHAKOSKI A
ARANKO K
NEUVONEN PJ
Citation: E. Lukkari et al., ITRACONAZOLE MODERATELY INCREASES SERUM CONCENTRATIONS OF OXYBUTYNIN BUT DOES NOT AFFECT THOSE OF THE ACTIVE METABOLITE, European Journal of Clinical Pharmacology, 52(5), 1997, pp. 403-406
Authors:
KRISHNAN KR
FOWLER C
POWELL J
SONI BM
LUKKARI E
VAIDYANATHAN S
Citation: Kr. Krishnan et al., A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER STUDY OF INTRAVESICAL OXYBUTYNIN IN THE SYMPTOMATIC RELIEF OF URGE INCONTINENCE IN PATIENTS WITH DETRUSOR INSTABILITY HYPERREFLEXIA (VOL 15, PG 307, 1996)/, Neurourol. urodyn., 15(6), 1996, pp. 674-676
Authors:
LUKKARI E
CASTRENKORTEKANGAS P
JUHAKOSKI A
LOYTTYNIEMI E
ARANKO K
NEUVONEN PJ
Citation: E. Lukkari et al., EFFECT OF FOOD ON THE BIOAVAILABILITY OF OXYBUTYNIN FROM A CONTROLLED-RELEASE TABLET, European Journal of Clinical Pharmacology, 50(3), 1996, pp. 221-223
Risultati:
1-7
|